Marco Meglio, Editor for NeurologyLive, has been with the team since October 2019. Follow him on Twitter @marcomeglio1 or email him at mmeglio@neurologylive.com
Opting for Epilepsy Surgery: How a Risk Assessment Tool Can Help Provide Expectations
January 17th 2020Lara Jehi, MD, professor of neurology and an epilepsy specialist at the Cleveland Clinic Lerner College of Medicine, detailed the process and decisions that patients with epilepsy face when considering surgery.
Tapping Into Individualized Risk Prediction in Epilepsy Surgery Candidates
January 15th 2020Lara Jehi, MD, professor of neurology and an epilepsy specialist at the Cleveland Clinic Lerner College of Medicine, spoke to her work on individualized risk assessments for epilepsy surgery candidates and the impact it can have for both physicians and patients alike.
The Potential of Altering the Gut Microbiome for Brain Health
January 11th 2020Daniel Lowenstein, MD, professor of neurology and executive vice chancellor and provost at the University of California, San Francisco, discussed the ongoing trials and steps being taken to turn the gut microbiome into a realistic therapeutic option for patients with epilepsy.
Cleveland Clinic Names Epilepsy Specialist as Inaugural Chief Research Information Officer
January 9th 2020Lara Jehi, MD, professor of neurology and co-director of Network Capacity for the Clinical and Translational Science Collaborative of Cleveland Clinic, has been appointed as the inaugural chief research information officer.
New Relapsing MS Trial Seeks to Compare Stem Cell Transplant With Biologic Drugs
January 7th 2020The trial will determine whether autologous hematopoietic stem cell transplantation is a more appropriate treatment option for patients with severe forms of relapsing MS compared to currently available biologic drugs.
Trial Will Assess Blood-Based Biomarker to Distinguish Epileptic From Psychogenic Seizures
December 15th 2019A new trial will aim to confirm the findings of a previous study that showed novel combinations of peripherally circulating proteins coupled with risk factors can provide a diagnostic tool with significant clinical unity.